Surprisingly, in vivo studies show higher expression of PD-L1 in CD8+T cells in KEAP1null/KRASG12D-mutant tumours as compared to KEAP1WT/KRASG12C tumours [72], suggesting the role of KEAP1 in regulating the immune response and immunosuppression. Here, KEAP1 is linked to neoplasm.